Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

Objective: To study the safety and efficacy of a cholinesterase inhibitor, donepezil hydrochloride, for the treatment of dementia in Parkinson's disease (PD). Methods: This was a randomised double blind, placebo controlled, crossover study in 22 subjects with PD and dementia. Participants were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ravina, B, Putt, M, Siderowf, A, Farrar, J, Gillespie, M, Crawley, A, Fernandez, H, Trieschmann, M, Reichwein, S, Simuni, T
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2005
Assuntos:
Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1739697/
https://ncbi.nlm.nih.gov/pubmed/15965198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2004.050682
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados